Posterior Inferior Cerebellar Artery Patency after Flow-Diverting Stent Treatment

References

1. 1.↵
   2. Becske T,
   3. Kallmes DF,
   4. Saatci I, et al

   . Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology 2013;267:858–68 doi:10.1148/radiol.13120099 pmid:23418004

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Siddiqui AH,
   3. Abla AA,
   4. Kan P, et al

   . Panacea or problem: flow diverters in the treatment of symptomatic large or giant fusiform vertebrobasilar aneurysms. J Neurosurg 2012;116:1258–66 doi:10.3171/2012.2.JNS111942 pmid:22404673

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Ertl L,
   3. Holtmannspotter M,
   4. Patzig M, et al

   . Use of flow-diverting devices in fusiform vertebrobasilar giant aneurysms: a report on periprocedural course and long-term follow-up. AJNR Am J Neuroradiol 2014;35:1346–52 doi:10.3174/ajnr.A3859 pmid:24578280

   Abstract/FREE Full Text
4. 4.↵
   2. Albuquerque FC,
   3. Park MS,
   4. Abla AA, et al

   . A reappraisal of the Pipeline embolization device for the treatment of posterior circulation aneurysms. J Neurointerv Surg 2015;7:641–45 doi:10.1136/neurintsurg-2014-011340 pmid:25092926

   Abstract/FREE Full Text
5. 5.↵
   2. Nelson PK,
   3. Lylyk P,
   4. Szikora I, et al

   . The Pipeline embolization device for the intracranial treatment of aneurysms trial. AJNR Am J Neuroradiol 2011;32:34–40 doi:10.3174/ajnr.A2421 pmid:21148256

   Abstract/FREE Full Text
6. 6.↵
   2. Yu SC,
   3. Kwok CK,
   4. Cheng PW, et al

   . Intracranial aneurysms: midterm outcome of Pipeline embolization device–a prospective study in 143 patients with 178 aneurysms. Radiology 2012;265:893–901 doi:10.1148/radiol.12120422 pmid:22996749

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Moon K,
   3. Albuquerque FC,
   4. Ducruet AF, et al

   . Treatment of ophthalmic segment carotid aneurysms using the Pipeline embolization device: clinical and angiographic follow-up. Neurol Res 2014;36:344–50 doi:10.1179/1743132814Y.0000000322 pmid:24617935

   CrossRefPubMed
8. 8.↵
   2. Puffer RC,
   3. Kallmes DF,
   4. Cloft HJ, et al

   . Patency of the ophthalmic artery after flow diversion treatment of paraclinoid aneurysms. J Neurosurg 2012;116:892–96 doi:10.3171/2011.11.JNS111612 pmid:22224787

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Vedantam A,
   3. Rao VY,
   4. Shaltoni HM, et al

   . Incidence and clinical implications of carotid branch occlusion following treatment of internal carotid artery aneurysms with the Pipeline embolization device. Neurosurgery 2015;76:173–78; discussion 178 doi:10.1227/NEU.0000000000000595 pmid:25549190

   CrossRefPubMed
10. 10.↵
    2. Brinjikji W,
    3. Lanzino G,
    4. Cloft HJ, et al

    . Patency of the posterior communicating artery after flow diversion treatment of internal carotid artery aneurysms. Clin Neurol Neurosurg 2014;120:84–88 doi:10.1016/j.clineuro.2014.02.018 pmid:24731582

    CrossRefPubMed
11. 11.↵
    2. Raz E,
    3. Shapiro M,
    4. Becske T, et al

    . Anterior choroidal artery patency and clinical follow-up after coverage with the Pipeline embolization device. AJNR Am J Neuroradiol 2015;36:937–42 doi:10.3174/ajnr.A4217 pmid:25572948

    Abstract/FREE Full Text
12. 12.↵
    2. Brinjikji W,
    3. Kallmes DF,
    4. Cloft HJ, et al

    . Patency of the anterior choroidal artery after flow-diversion treatment of internal carotid artery aneurysms. AJNR Am J Neuroradiol 2015;36:537–41 doi:10.3174/ajnr.A4139 pmid:25339646

    Abstract/FREE Full Text
13. 13.↵
    2. Gascou G,
    3. Lobotesis K,
    4. Brunel H, et al

    . Extra-aneurysmal flow modification following Pipeline embolization device implantation: focus on regional branches, perforators, and the parent vessel. AJNR Am J Neuroradiol 2015;36:725–31 doi:10.3174/ajnr.A4191 pmid:25523592

    Abstract/FREE Full Text
14. 14.↵
    2. van Rooij WJ,
    3. Sluzewski M

    . Perforator infarction after placement of a Pipeline flow-diverting stent for an unruptured A1 aneurysm. AJNR Am J Neuroradiol 2010;31:E43–E44 doi:10.3174/ajnr.A2034 pmid:20150311

    FREE Full Text
15. 15.↵
    2. Phillips TJ,
    3. Wenderoth JD,
    4. Phatouros CC, et al

    . Safety of the Pipeline embolization device in treatment of posterior circulation aneurysms. AJNR Am J Neuroradiol 2012;33:1225–31 doi:10.3174/ajnr.A3166 pmid:22678845

    Abstract/FREE Full Text
16. 16.↵
    2. Shapiro M,
    3. Raz E,
    4. Becske T, et al

    . Variable porosity of the Pipeline embolization device in straight and curved vessels: a guide for optimal deployment strategy. AJNR Am J Neuroradiol 2014;35:727–33 doi:10.3174/ajnr.A3742 pmid:24072622

    Abstract/FREE Full Text
17. 17.↵
    2. Pai BS,
    3. Varma RG,
    4. Kulkarni RN, et al

    . Microsurgical anatomy of the posterior circulation. Neurol India 2007;55:31–41 doi:10.4103/0028-3886.30424 pmid:17272897

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Erdogmus S,
    3. Govsa F

    . Anatomic features of the intracranial and intracanalicular portions of ophthalmic artery: for the surgical procedures. Neurosurg Rev 2006;29:213–18 doi:10.1007/s10143-006-0028-6 pmid:16775743

    CrossRefPubMed
19. 19.↵
    2. Govsa F,
    3. Erturk M,
    4. Kayalioglu G, et al

    . Neuro-arterial relations in the region of the optic canal. Surg Radiol Anat 1999;21:329–35 doi:10.1007/BF01631334 pmid:10635097

    CrossRefPubMed
20. 20.↵
    2. Hong B,
    3. Wang K,
    4. Huang Q, et al

    . Effects of metal coverage rate of flow diversion device on neointimal growth at side branch ostium and stented artery: an animal experiment in rabbit abdominal aorta. Neuroradiology 2012;54:849–55 doi:10.1007/s00234-011-0984-6 pmid:22170078

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Dai D,
    3. Ding YH,
    4. Kadirvel R, et al

    . Patency of branches after coverage with multiple telescoping flow-diverter devices: an in vivo study in rabbits. AJNR Am J Neuroradiol 2012;33:171–74 doi:10.3174/ajnr.A2879 pmid:22158925

    Abstract/FREE Full Text
22. 22.↵
    2. Kallmes DF,
    3. Ding YH,
    4. Dai D, et al

    . A new endoluminal, flow-disrupting device for treatment of saccular aneurysms. Stroke 2007;38:2346–52 pmid:17615366

    Abstract/FREE Full Text